2022 Q4 Form 10-Q Financial Statement

#000095012322012413 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $1.879M $18.58M $16.54M
YoY Change -88.78% 12.34% 7.51%
Cost Of Revenue $2.311M $8.379M $7.097M
YoY Change -71.16% 18.06% 1.39%
Gross Profit -$432.0K $10.20M $9.441M
YoY Change -104.94% 8.04% -2.67%
Gross Profit Margin -22.99% 54.9% 57.09%
Selling, General & Admin $2.061M $1.487M $1.573M
YoY Change 40.68% -5.47% 11.32%
% of Gross Profit 14.58% 16.66%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization -$1.980M $2.569M $2.250M
YoY Change -213.21% 14.18% -3.81%
% of Gross Profit 25.19% 23.83%
Operating Expenses $2.061M $1.487M $1.573M
YoY Change 40.68% -5.47% 11.32%
Operating Profit -$2.788M -$985.0K $1.001M
YoY Change 49.49% -198.4% -187.12%
Interest Expense $1.955M $1.996M $1.362M
YoY Change 43.54% 46.55% 18.95%
% of Operating Profit 136.06%
Other Income/Expense, Net $10.52M -$7.358M -$896.0K
YoY Change -546.12% 721.21% -64.44%
Pretax Income $29.46M -$8.343M $105.0K
YoY Change -797.49% -8045.71% -102.86%
Income Tax -$231.0K $196.0K -$1.000K
% Of Pretax Income -0.78% -0.95%
Net Earnings $29.53M -$8.291M -$200.0K
YoY Change -796.79% 4045.5% -94.44%
Net Earnings / Revenue 1571.58% -44.63% -1.21%
Basic Earnings Per Share $1.02 -$0.29 -$0.01
Diluted Earnings Per Share $0.74 -$0.29 -$7.698K
COMMON SHARES
Basic Shares Outstanding 30.02M 29.62M 25.98M
Diluted Shares Outstanding 40.59M 28.54M 25.98M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $73.51M $63.89M $72.34M
YoY Change -0.25% -11.68% 143.57%
Cash & Equivalents $18.97M $23.27M $21.79M
Short-Term Investments $54.54M $40.62M $50.55M
Other Short-Term Assets $80.34M $1.391M $5.743M
YoY Change 4563.03% -75.78% 187.15%
Inventory $1.017M $1.071M
Prepaid Expenses
Receivables $5.854M $5.544M
Other Receivables $2.578M $1.895M
Total Short-Term Assets $156.2M $74.73M $86.59M
YoY Change 88.29% -13.7% 56.87%
LONG-TERM ASSETS
Property, Plant & Equipment $46.00K $503.0K $885.0K
YoY Change -93.77% -43.16% -98.66%
Goodwill $52.46M $52.46M
YoY Change 0.0% 4.91%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $143.0K $253.0K $256.0K
YoY Change -43.92% -1.17% -84.0%
Total Long-Term Assets $13.52M $83.55M $74.53M
YoY Change -81.53% 12.11% -43.75%
TOTAL ASSETS
Total Short-Term Assets $156.2M $74.73M $86.59M
Total Long-Term Assets $13.52M $83.55M $74.53M
Total Assets $169.7M $158.3M $161.1M
YoY Change 8.68% -1.76% -14.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $80.00K $6.340M $5.108M
YoY Change -98.52% 24.12% 4.24%
Accrued Expenses $2.077M $7.498M $19.65M
YoY Change -89.66% -61.83% 250.8%
Deferred Revenue $1.250M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $24.25M $9.643M $2.927M
YoY Change 843.17% 229.45% -45.8%
Total Short-Term Liabilities $44.45M $24.73M $30.96M
YoY Change 47.08% -20.12% 46.03%
LONG-TERM LIABILITIES
Long-Term Debt $61.81M $95.26M $68.99M
YoY Change -11.57% 38.09% -28.73%
Other Long-Term Liabilities $527.0K $977.0K $4.535M
YoY Change 51.44% -78.46% 0.78%
Total Long-Term Liabilities $527.0K $977.0K $73.52M
YoY Change 51.44% -98.67% -27.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $44.45M $24.73M $30.96M
Total Long-Term Liabilities $527.0K $977.0K $73.52M
Total Liabilities $107.6M $124.4M $117.5M
YoY Change 3.97% 5.84% -9.75%
SHAREHOLDERS EQUITY
Retained Earnings -$3.258B -$3.288B
YoY Change -0.33%
Common Stock $29.00K $29.00K
YoY Change 7.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $56.15M $26.04M $43.62M
YoY Change
Total Liabilities & Shareholders Equity $169.7M $158.3M $161.1M
YoY Change 8.68% -1.76% -14.16%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income $29.53M -$8.291M -$200.0K
YoY Change -796.79% 4045.5% -94.44%
Depreciation, Depletion And Amortization -$1.980M $2.569M $2.250M
YoY Change -213.21% 14.18% -3.81%
Cash From Operating Activities $2.414M $2.024M -$1.034M
YoY Change -41.75% -295.74% -160.01%
INVESTING ACTIVITIES
Capital Expenditures $421.0K $74.00K $48.00K
YoY Change -371.61% 54.17% 9.09%
Acquisitions $1.250M
YoY Change
Other Investing Activities $13.34M $339.0K -$622.0K
YoY Change 6506.44% -154.5% -95.33%
Cash From Investing Activities $12.92M -$2.270M -$3.171M
YoY Change 27397.87% -28.41% -78.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -18.32M -84.00K 1.614M
YoY Change 1685.38% -105.2% -133.5%
NET CHANGE
Cash From Operating Activities 2.414M 2.024M -1.034M
Cash From Investing Activities 12.92M -2.270M -3.171M
Cash From Financing Activities -18.32M -84.00K 1.614M
Net Change In Cash -2.980M -330.0K -2.591M
YoY Change -194.15% -87.26% -85.65%
FREE CASH FLOW
Cash From Operating Activities $2.414M $2.024M -$1.034M
Capital Expenditures $421.0K $74.00K $48.00K
Free Cash Flow $1.993M $1.950M -$1.082M
YoY Change -53.64% -280.22% -164.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q3 dei Amendment Flag
AmendmentFlag
false
CY2022Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001831096
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2022Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q3 dei Document Type
DocumentType
10-Q
CY2022Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q3 dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
CY2022Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q3 dei Entity File Number
EntityFileNumber
001-39832
CY2022Q3 dei Entity Registrant Name
EntityRegistrantName
Great Elm Group, Inc.
CY2022Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-3622015
CY2022Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
800 South Street
CY2022Q3 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 230
CY2022Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Waltham
CY2022Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2022Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02453
CY2022Q3 dei City Area Code
CityAreaCode
617
CY2022Q3 dei Local Phone Number
LocalPhoneNumber
375-3006
CY2022Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q3 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
30022424
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23265000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23595000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5854000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5867000
CY2022Q3 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
2578000
CY2022Q2 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
2445000
CY2022Q3 geg Investments Cost Basis
InvestmentsCostBasis
62531000
CY2022Q2 geg Investments Cost Basis
InvestmentsCostBasis
68766000
CY2022Q3 us-gaap Investments
Investments
40624000
CY2022Q2 us-gaap Investments
Investments
48042000
CY2022Q3 us-gaap Inventory Net
InventoryNet
1017000
CY2022Q2 us-gaap Inventory Net
InventoryNet
898000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1391000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1050000
CY2022Q3 geg Consolidated Investments Cost Basis
ConsolidatedInvestmentsCostBasis
0
CY2022Q2 geg Consolidated Investments Cost Basis
ConsolidatedInvestmentsCostBasis
2432000
CY2022Q2 geg Consolidated Investments Assets At Fair Value
ConsolidatedInvestmentsAssetsAtFairValue
1797000
CY2022Q2 geg Consolidated Prepaid Expense
ConsolidatedPrepaidExpense
746000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
74729000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
84440000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
503000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
538000
CY2022Q3 geg Equipment Held For Rental Net
EquipmentHeldForRentalNet
7923000
CY2022Q2 geg Equipment Held For Rental Net
EquipmentHeldForRentalNet
7504000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18592000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
19171000
CY2022Q3 us-gaap Goodwill
Goodwill
52463000
CY2022Q2 us-gaap Goodwill
Goodwill
52463000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3815000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3722000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
253000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
249000
CY2022Q3 us-gaap Assets
Assets
158278000
CY2022Q2 us-gaap Assets
Assets
168087000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
6340000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
6038000
CY2022Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
5814000
CY2022Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
7389000
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1250000
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1218000
CY2022Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
73000
CY2022Q2 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
486000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1684000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1559000
CY2022Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
5661000
CY2022Q3 geg Current Portion Of Equipment Financing Debt
CurrentPortionOfEquipmentFinancingDebt
3909000
CY2022Q2 geg Current Portion Of Equipment Financing Debt
CurrentPortionOfEquipmentFinancingDebt
2993000
CY2022Q2 geg Accrued Expenses And Other Consolidated Funds
AccruedExpensesAndOtherConsolidatedFunds
11000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
24731000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
19694000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2342000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2375000
CY2022Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
26945000
CY2022Q3 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
25597000
CY2022Q2 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
25532000
CY2022Q3 us-gaap Accounts Payable Related Parties Noncurrent
AccountsPayableRelatedPartiesNoncurrent
1050000
CY2022Q2 us-gaap Accounts Payable Related Parties Noncurrent
AccountsPayableRelatedPartiesNoncurrent
1120000
CY2022Q2 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
6270000
CY2022Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
36085000
CY2022Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
36085000
CY2022Q3 geg Convertible Notes Payable Held By Related Party Non Current
ConvertibleNotesPayableHeldByRelatedPartyNonCurrent
14653000
CY2022Q2 geg Convertible Notes Payable Held By Related Party Non Current
ConvertibleNotesPayableHeldByRelatedPartyNonCurrent
15133000
CY2022Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
35216000
CY2022Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
35187000
CY2022Q3 geg Redeemable Preferred Stock Held By Related Party Non Current
RedeemablePreferredStockHeldByRelatedPartyNonCurrent
35417000
CY2022Q2 geg Redeemable Preferred Stock Held By Related Party Non Current
RedeemablePreferredStockHeldByRelatedPartyNonCurrent
35824000
CY2022Q3 geg Redeemable Preferred Stock Of Subsidiaries
RedeemablePreferredStockOfSubsidiaries
34450000
CY2022Q2 geg Redeemable Preferred Stock Of Subsidiaries
RedeemablePreferredStockOfSubsidiaries
34747000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
977000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
908000
CY2022Q3 us-gaap Liabilities
Liabilities
124363000
CY2022Q2 us-gaap Liabilities
Liabilities
125833000
CY2022Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
2887000
CY2022Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
2225000
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30046829
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28774320
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28932444
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28507490
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
29000
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
29000
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3313597000
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3312763000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3287587000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3279296000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
26039000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
33496000
CY2022Q3 us-gaap Minority Interest
MinorityInterest
4989000
CY2022Q2 us-gaap Minority Interest
MinorityInterest
6533000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
31028000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40029000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
158278000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
168087000
CY2022Q3 us-gaap Revenues
Revenues
18579000
CY2021Q3 us-gaap Revenues
Revenues
16538000
CY2022Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
8971000
CY2021Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
6253000
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
681000
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
562000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1487000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1573000
CY2022Q3 geg Expenses Of Consolidated Funds
ExpensesOfConsolidatedFunds
46000
CY2021Q3 geg Expenses Of Consolidated Funds
ExpensesOfConsolidatedFunds
52000
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
19564000
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
15537000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-985000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1001000
CY2022Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1473000
CY2021Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
653000
CY2022Q3 geg Realized And Unrealized Gain Loss On Investments
RealizedAndUnrealizedGainLossOnInvestments
-6797000
CY2021Q3 geg Realized And Unrealized Gain Loss On Investments
RealizedAndUnrealizedGainLossOnInvestments
-14000
CY2022Q3 geg Net Realized And Unrealized Gain On Investments Of Consolidated Funds
NetRealizedAndUnrealizedGainOnInvestmentsOfConsolidatedFunds
-16000
CY2021Q3 geg Net Realized And Unrealized Gain On Investments Of Consolidated Funds
NetRealizedAndUnrealizedGainOnInvestmentsOfConsolidatedFunds
-189000
CY2022Q3 us-gaap Interest Expense
InterestExpense
1996000
CY2021Q3 us-gaap Interest Expense
InterestExpense
1362000
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-23000
CY2022Q3 geg Other Nonoperating Income Net
OtherNonoperatingIncomeNet
1000
CY2021Q3 geg Other Nonoperating Income Net
OtherNonoperatingIncomeNet
16000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8343000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
105000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
196000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-8539000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
106000
CY2022Q3 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-248000
CY2021Q3 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
306000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-8291000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-200000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.29
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.29
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28543000
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25982000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28543000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25982000
CY2021Q3 geg Cares Act Stimulus Amount
CARESActStimulusAmount
2321000
CY2021Q3 geg Cares Act Stimulus Amount Of Selling General And Administrative
CARESActStimulusAmountOfSellingGeneralAndAdministrative
84000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
40029000
CY2022Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
2225000
CY2022Q3 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-9201000
CY2022Q3 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
662000
CY2022Q3 geg Distributions To Non Controlling Interests In Consolidated Fund
DistributionsToNonControllingInterestsInConsolidatedFund
634000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
834000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
31028000
CY2022Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
2887000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
52785000
CY2021Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
2639000
CY2021Q3 us-gaap Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
-99000
CY2021Q3 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
205000
CY2021Q3 geg Issuance Of Interests In Consolidated Fund
IssuanceOfInterestsInConsolidatedFund
527000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
581000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
53794000
CY2021Q3 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
2844000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-8539000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
106000
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2569000
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2250000
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
834000
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
581000
CY2022Q3 geg Sales Of Investments By Consolidated Funds
SalesOfInvestmentsByConsolidatedFunds
1558000
CY2021Q3 geg Sales Of Investments By Consolidated Funds
SalesOfInvestmentsByConsolidatedFunds
2620000
CY2021Q3 geg Purchases Of Investments By Consolidated Fund
PurchasesOfInvestmentsByConsolidatedFund
3276000
CY2021Q3 geg Unrealized Gain Loss On Investments From Consolidated Funds
UnrealizedGainLossOnInvestmentsFromConsolidatedFunds
-90000
CY2022Q3 geg Realized Gain Loss On Investments From Consolidated Funds
RealizedGainLossOnInvestmentsFromConsolidatedFunds
-16000
CY2021Q3 geg Realized Gain Loss On Investments From Consolidated Funds
RealizedGainLossOnInvestmentsFromConsolidatedFunds
-99000
CY2022Q3 geg Unrealized Gain Loss On Investments Including Investments Of Consolidated Fund
UnrealizedGainLossOnInvestmentsIncludingInvestmentsOfConsolidatedFund
-1182000
CY2021Q3 geg Unrealized Gain Loss On Investments Including Investments Of Consolidated Fund
UnrealizedGainLossOnInvestmentsIncludingInvestmentsOfConsolidatedFund
639000
CY2022Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-5615000
CY2021Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-653000
CY2022Q3 geg Non Cash Interest And Amortization Of Capitalized Issuance Costs
NonCashInterestAndAmortizationOfCapitalizedIssuanceCosts
146000
CY2021Q3 geg Non Cash Interest And Amortization Of Capitalized Issuance Costs
NonCashInterestAndAmortizationOfCapitalizedIssuanceCosts
90000
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-23000
CY2022Q3 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
172000
CY2021Q3 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-1000
CY2022Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-158000
CY2021Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-561000
CY2022Q3 geg Gain On Sale Of Equipment Held For Rental
GainOnSaleOfEquipmentHeldForRental
106000
CY2021Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-163000
CY2021Q3 geg Gain On Sale Of Equipment Held For Rental
GainOnSaleOfEquipmentHeldForRental
43000
CY2022Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-58000
CY2022Q3 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
133000
CY2021Q3 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
326000
CY2022Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13000
CY2021Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-974000
CY2022Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
119000
CY2021Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5000
CY2022Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-401000
CY2021Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1372000
CY2022Q3 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1000
CY2021Q3 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-568000
CY2022Q3 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
32000
CY2021Q3 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1159000
CY2022Q3 geg Increase Decrease In Accounts Payable Accrued Liabilities And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndOtherLiabilities
-1739000
CY2021Q3 geg Increase Decrease In Accounts Payable Accrued Liabilities And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndOtherLiabilities
-1506000
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2024000
CY2021Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1034000
CY2021Q3 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1250000
CY2021Q3 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
165000
CY2021Q3 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
187000
CY2022Q3 us-gaap Payments To Acquire Equipment On Lease
PaymentsToAcquireEquipmentOnLease
2535000
CY2021Q3 us-gaap Payments To Acquire Equipment On Lease
PaymentsToAcquireEquipmentOnLease
2501000
CY2022Q3 geg Proceeds From Sale Of Equipment Held For Rental
ProceedsFromSaleOfEquipmentHeldForRental
339000
CY2021Q3 geg Proceeds From Sale Of Equipment Held For Rental
ProceedsFromSaleOfEquipmentHeldForRental
606000
CY2022Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
74000
CY2021Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
48000
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2270000
CY2021Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3171000
CY2022Q3 geg Principal Payments On Equipment Financing Debt
PrincipalPaymentsOnEquipmentFinancingDebt
1746000
CY2021Q3 geg Principal Payments On Equipment Financing Debt
PrincipalPaymentsOnEquipmentFinancingDebt
1155000
CY2022Q3 geg Proceeds From Equipment Financing
ProceedsFromEquipmentFinancing
2662000
CY2021Q3 geg Proceeds From Equipment Financing
ProceedsFromEquipmentFinancing
2083000
CY2021Q3 geg Due To Broker Of Consolidated Funds
DueToBrokerOfConsolidatedFunds
186000
CY2022Q3 geg Redemption Of Redeemable Preferred Stock Of Subsidiary
RedemptionOfRedeemablePreferredStockOfSubsidiary
366000
CY2022Q3 geg Distributions To Non Controlling Interests In Consolidated Funds
DistributionsToNonControllingInterestsInConsolidatedFunds
-634000
CY2021Q3 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
500000
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-84000
CY2021Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1614000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-330000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2591000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
23595000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24382000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
23265000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21791000
CY2021Q3 us-gaap Interest Paid Net
InterestPaidNet
831000
CY2022Q3 us-gaap Interest Paid Net
InterestPaidNet
1353000
CY2022Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
552000
CY2021Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
504000
CY2022Q3 geg Partial Settlement Of Note In Exchange For Stock
PartialSettlementOfNoteInExchangeForStock
609000
CY2022Q3 geg Non Cash Distributions Received From Consolidated Fund
NonCashDistributionsReceivedFromConsolidatedFund
177000
CY2021Q3 us-gaap Consideration Received For Beneficial Interest Obtained For Transferring Financial Asset
ConsiderationReceivedForBeneficialInterestObtainedForTransferringFinancialAsset
497000
CY2022Q3 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2022Q3 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of these financial statements in accordance with accounting principles generally accepted in the United States of America (</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">US GAAP</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">) requires the Company to make estimates and assumptions that affect the reported amounts in the financial statements and disclosures of contingent assets and liabilities. On an on-going basis, the Company evaluates all of these estimates and assumptions. Included in these estimates and assumptions are items that relate to revenue recognition, recognition of rental income, the valuation of excess and obsolete inventories, depreciable lives of equipment, impairment of long lived tangible and intangible assets, valuation allowance for deferred tax assets, fair value measurements including stock-based compensation and contingent consideration, estimates associated with the application of acquisition accounting, and the value of lease liabilities and corresponding right of use assets. Although these and other estimates and assumptions are based on the best available information, actual results could be different from these estimates.</span></p>
CY2022Q3 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2022Q3 geg Revenue Reserve
RevenueReserve
1500000
CY2022Q2 geg Revenue Reserve
RevenueReserve
1900000
CY2022Q3 geg Increase Decrease In Revenue
IncreaseDecreaseInRevenue
-500000
CY2021Q3 geg Increase Decrease In Revenue
IncreaseDecreaseInRevenue
-1000000.0
CY2022Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
300000
CY2022Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
400000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-8539000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
106000
CY2022Q3 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-248000
CY2021Q3 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
306000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-8291000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-200000
CY2022Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
28543000
CY2021Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
25982000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28543000
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25982000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.29
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.29
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13249948
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13429986
CY2022Q3 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
1303386
CY2021Q3 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
811360
CY2022Q3 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Concentration of Risk</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company’s net investment revenue and receivables for the periods presented were primarily attributable to the management of two investment vehicles, GECC and Monomoy UpREIT. See Note 4 – Related Party Transactions.</span></p><div style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company’s durable medical equipment revenue and related accounts receivable are concentrated with third-party Payors. The following table summarizes customer concentrations as a percentage of revenues:</span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:35.146%;"/> <td style="width:2.944%;"/> <td style="width:29.483%;"/> <td style="width:2.944%;"/> <td style="width:29.483%;"/> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td colspan="3" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the three months ended September 30,</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2022</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">2021</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government Payor</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">39</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">37</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third-party Payor</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td> </tr> </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The following table summarizes customer concentrations as a percentage of accounts receivable:</span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:35.146%;"/> <td style="width:2.944%;"/> <td style="width:29.483%;"/> <td style="width:2.944%;"/> <td style="width:29.483%;"/> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td colspan="3" style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">As of</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">September 30, 2022</span></p></td> <td style="border-top:0.5pt solid rgba(255,255,255,0.01);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">June 30, 2022</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Government Payor</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">29</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10.0pt;"> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Third-party Payor</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">13</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"/> </p></td> <td style="background-color:rgba(207,240,252,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">14</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%</span></p></td> </tr> </table></div>
CY2022Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
5691000
CY2021Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
5479000
CY2022Q3 us-gaap Revenues
Revenues
18579000
CY2021Q3 us-gaap Revenues
Revenues
16538000
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0
CY2022Q3 geg Incentive Fee Earned As Percentage On Investment Performance
IncentiveFeeEarnedAsPercentageOnInvestmentPerformance
0.20
CY2022Q3 geg Accrued Incentive Fee Earned Based On Investment Performance
AccruedIncentiveFeeEarnedBasedOnInvestmentPerformance
0
CY2022Q3 geg Consolidated Funds
ConsolidatedFunds
0
CY2022Q3 geg Fair Value Liabilities Level1 To Level2 Transfer Amount
FairValueLiabilitiesLevel1ToLevel2TransferAmount
0
CY2021Q3 geg Fair Value Liabilities Level1 To Level2 Transfer Amount
FairValueLiabilitiesLevel1ToLevel2TransferAmount
0
CY2022Q3 geg Fair Value Liabilities Level2 To Level1 Transfer Amount
FairValueLiabilitiesLevel2ToLevel1TransferAmount
0
CY2021Q3 geg Fair Value Liabilities Level2 To Level1 Transfer Amount
FairValueLiabilitiesLevel2ToLevel1TransferAmount
0
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2022Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
40624000
CY2022Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1709000
CY2022Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1709000
CY2022Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
49838000
CY2022Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1767000
CY2022Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
1767000
CY2022Q3 geg Fair Value Assets Level1 To Level2 Transfer Amount
FairValueAssetsLevel1ToLevel2TransferAmount
0
CY2021Q3 geg Fair Value Assets Level1 To Level2 Transfer Amount
FairValueAssetsLevel1ToLevel2TransferAmount
0
CY2022Q3 geg Fair Value Assets Level2 To Level1 Transfer Amount
FairValueAssetsLevel2ToLevel1TransferAmount
0
CY2021Q3 geg Fair Value Assets Level2 To Level1 Transfer Amount
FairValueAssetsLevel2ToLevel1TransferAmount
0
CY2022Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1767000
CY2021Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
271000
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
0
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
497000
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-58000
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-163000
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1709000
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
605000
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2022Q3 geg Notice Period For Annually Allowable Redemptions
NoticePeriodForAnnuallyAllowableRedemptions
P90D
CY2022Q3 geg Lockup Period From Date Of Investment
LockupPeriodFromDateOfInvestment
P1Y
CY2022Q3 geg Participation Feature Of Hcllc Series A2 Preferred Stock Liability Fair Value Disclosure
ParticipationFeatureOfHCLLCSeriesA2PreferredStockLiabilityFairValueDisclosure
0
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3023000
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2958000
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2520000
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2420000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
503000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
538000
CY2022Q3 geg Medical Equipment Held For Rental Gross
MedicalEquipmentHeldForRentalGross
17544000
CY2022Q2 geg Medical Equipment Held For Rental Gross
MedicalEquipmentHeldForRentalGross
16593000
CY2022Q3 geg Equipment Held For Rental Accumulated Depreciation
EquipmentHeldForRentalAccumulatedDepreciation
9621000
CY2022Q2 geg Equipment Held For Rental Accumulated Depreciation
EquipmentHeldForRentalAccumulatedDepreciation
9089000
CY2022Q3 geg Equipment Held For Rental Net
EquipmentHeldForRentalNet
7923000
CY2022Q2 geg Equipment Held For Rental Net
EquipmentHeldForRentalNet
7504000
CY2022Q3 us-gaap Depreciation
Depreciation
1990000
CY2021Q3 us-gaap Depreciation
Depreciation
1831000
CY2022Q2 us-gaap Goodwill
Goodwill
52463000
CY2021Q2 us-gaap Goodwill
Goodwill
50536000
CY2021Q3 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
1927000
CY2022Q3 us-gaap Goodwill
Goodwill
52463000
CY2021Q3 us-gaap Goodwill
Goodwill
52463000
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
26887000
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8295000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18592000
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
26887000
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7716000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
19171000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
579000
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
419000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1703000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2084000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1974000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1912000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1838000
CY2022Q3 geg Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
9081000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18592000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1410000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1641000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
786000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
646000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
152000
CY2022Q3 geg Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
21000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
4656000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
630000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
4026000
CY2022Q3 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2024-10-01
CY2022Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P88M
CY2022Q3 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2022Q3 geg Lessee Operating Lease Optional Lease Extension Period
LesseeOperatingLeaseOptionalLeaseExtensionPeriod
P60M
CY2022Q3 us-gaap Interest Expense Other
InterestExpenseOther
700000
CY2021Q3 us-gaap Interest Expense Other
InterestExpenseOther
10000.00
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
3909000
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
5661000
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
26945000
CY2022Q3 geg Long Term Debt Maturities Repayments Due
LongTermDebtMaturitiesRepaymentsDue
36515000
CY2022Q3 geg Minority Interest Including Temporary Equity And Preferred Stock Classified As Liability
MinorityInterestIncludingTemporaryEquityAndPreferredStockClassifiedAsLiability
7876000
CY2022Q2 geg Minority Interest Including Temporary Equity And Preferred Stock Classified As Liability
MinorityInterestIncludingTemporaryEquityAndPreferredStockClassifiedAsLiability
8758000
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-248000
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
306000
CY2022Q2 geg Redeemable Preferred Stock Of Subsidiaries Shares
RedeemablePreferredStockOfSubsidiariesShares
73110000
CY2022Q3 geg Redemption Of Preferred Stock During Period Shares
RedemptionOfPreferredStockDuringPeriodShares
407000
CY2022Q3 geg Redeemable Preferred Stock Of Subsidiaries Shares
RedeemablePreferredStockOfSubsidiariesShares
72703000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2134000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.68
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y4M2D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
125000
CY2022Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.60
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
732000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
3.59
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1527000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.72
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y7M17D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1436000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.70
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y8M1D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1527000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.72
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y7M17D
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
821000000
CY2022Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
211000000
CY2022Q3 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2022Q3 us-gaap Revenues
Revenues
18579000
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
681000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
941000
CY2022Q3 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
11552000
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
19564000
CY2022Q3 us-gaap Interest Expense
InterestExpense
1996000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5362000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7358000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8343000
CY2021Q3 us-gaap Revenues
Revenues
16538000
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
562000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
768000
CY2021Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
281000
CY2021Q3 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
8016000
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
15537000
CY2021Q3 us-gaap Interest Expense
InterestExpense
1362000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
466000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-896000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
105000
CY2022Q3 geg Fixed Assets Net
FixedAssetsNet
8426000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18592000
CY2022Q3 us-gaap Goodwill
Goodwill
52463000
CY2022Q3 us-gaap Other Assets
OtherAssets
78797000
CY2022Q3 us-gaap Assets
Assets
158278000
CY2022Q2 geg Fixed Assets Net
FixedAssetsNet
8042000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
19171000
CY2022Q2 us-gaap Goodwill
Goodwill
52463000
CY2022Q2 us-gaap Other Assets
OtherAssets
88411000
CY2022Q2 us-gaap Assets
Assets
168087000

Files In Submission

Name View Source Status
0000950123-22-012413-index-headers.html Edgar Link pending
0000950123-22-012413-index.html Edgar Link pending
0000950123-22-012413.txt Edgar Link pending
0000950123-22-012413-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
geg-20220930.htm Edgar Link pending
geg-20220930.xsd Edgar Link pending
geg-ex31_1.htm Edgar Link pending
geg-ex31_2.htm Edgar Link pending
geg-ex32_1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
geg-20220930_cal.xml Edgar Link unprocessable
geg-20220930_def.xml Edgar Link unprocessable
geg-20220930_lab.xml Edgar Link unprocessable
geg-20220930_pre.xml Edgar Link unprocessable
geg-20220930_htm.xml Edgar Link completed
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable